ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SNGX vs ENSC // ENTERPRISE SCALE & MARKET CAP

Soligenix Inc. (NASDAQ) VS. Ensysce Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: SNGX 1 — ENSC 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ENSC
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNGX VS. ENSC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SNGX ENSC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -2.80% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.5 40.2 +9.27 SNGX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $8.0M $8.5M -$484.1K ENSC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SNGX REV ENSC REV SNGX GROSS % ENSC GROSS % SNGX FCF ENSC FCF
FY 2025 $0 $5.1M — — -$10.3M -$7.9M
FY 2024 $119.4K $5.2M 0.0% — -$8.4M -$7.5M
FY 2023 $839.4K $2.2M — — -$8.6M -$10.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNGX // BETA —
ENSC // BETA —